114 related articles for article (PubMed ID: 25448825)
41. Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas.
Kuan CT; Wakiya K; Keir ST; Li J; Herndon JE; Pastan I; Bigner DD
Int J Cancer; 2011 Jul; 129(1):111-21. PubMed ID: 20824708
[TBL] [Abstract][Full Text] [Related]
42. Mutations of two lysine residues in the CDR loops of a recombinant immunotoxin that reduce its sensitivity to chemical derivatization.
Benhar I; Brinkmann U; Webber KO; Pastan I
Bioconjug Chem; 1994; 5(4):321-6. PubMed ID: 7948099
[TBL] [Abstract][Full Text] [Related]
43. [The construction of anti-EGFR single chain variable fragment fused with gelonin toxin prokaryotic expressing plasmid and the study of its anti-tumor effects].
Qiu J; Li Q; Li XL; Zhou XK; Huang NY; Li J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):621-4. PubMed ID: 22007484
[TBL] [Abstract][Full Text] [Related]
44. Optimization of the anti-(human CD3) immunotoxin DT389-scFv(UCHT1) N-terminal sequence to yield a homogeneous protein.
Hexham JM; King V; Dudas D; Graff P; Mahnke M; Wang YK; Goetschy JF; Plattner D; Zurini M; Bitsch F; Lake P; Digan ME
Biotechnol Appl Biochem; 2001 Dec; 34(3):183-7. PubMed ID: 11730486
[TBL] [Abstract][Full Text] [Related]
45. A divalent recombinant immunotoxin formed by a disulfide bond between the extension peptide chains.
Park JH; Kwon HW; Chung HK; Kim IH; Ahn K; Choi EJ; Pastan I; Choe M
Mol Cells; 2001 Dec; 12(3):398-402. PubMed ID: 11804341
[TBL] [Abstract][Full Text] [Related]
46. Preparation of an engineered safer immunotoxin against colon carcinoma based on the ribotoxin hirsutellin A.
Tomé-Amat J; Herrero-Galán E; Oñaderra M; Martínez-Del-Pozo Á; Gavilanes JG; Lacadena J
FEBS J; 2015 Jun; 282(11):2131-41. PubMed ID: 25752204
[TBL] [Abstract][Full Text] [Related]
47. [Preparation of anti-hCG single domain antibody by antibody grafting technique using an antigen-binding peptide].
Peng J; Wang Q; Cheng X; Liu M; Wang M; Xin H
Sheng Wu Gong Cheng Xue Bao; 2018 Apr; 34(4):569-577. PubMed ID: 29701030
[TBL] [Abstract][Full Text] [Related]
48. Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.
Piao H; Kuan CT; Chandramohan V; Keir ST; Pegram CN; Bao X; Månsson JE; Pastan IH; Bigner DD
MAbs; 2013; 5(5):748-62. PubMed ID: 23924792
[TBL] [Abstract][Full Text] [Related]
49. Crotamine-based recombinant immunotoxin targeting HER2 for enhanced cancer cell specificity and cytotoxicity.
Jang J; Nguyen MQ; Park S; Ryu D; Park H; Lee G; Kim CJ; Jang YJ; Choe H
Toxicon; 2023 Jul; 230():107157. PubMed ID: 37196787
[TBL] [Abstract][Full Text] [Related]
50. Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes.
Liu W; Onda M; Lee B; Kreitman RJ; Hassan R; Xiang L; Pastan I
Proc Natl Acad Sci U S A; 2012 Jul; 109(29):11782-7. PubMed ID: 22753489
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the immunogenicity of a single chain chimeric peptide composed of hCGβ and oLHα for inhibition of the growth of hCGβ-expressing cancer cells.
Jiang C; Jiang Y; Huang Z; Shen W; Wang J; Shen Q
Cancer Immunol Immunother; 2010 Dec; 59(12):1771-9. PubMed ID: 20809357
[TBL] [Abstract][Full Text] [Related]
52. Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Stepanov A; Belyy A; Kasheverov I; Rybinets A; Dronina M; Dyachenko I; Murashev A; Knorre V; Sakharov D; Ponomarenko N; Tsetlin V; Tonevitsky A; Deyev S; Belogurov A; Gabibov A
Biotechnol Lett; 2016 Jul; 38(7):1173-80. PubMed ID: 27099070
[TBL] [Abstract][Full Text] [Related]
53. Enhanced cytotoxicity of a
Masilamani AP; Huber N; Nagl C; Dettmer-Monaco V; Monaco G; Wolf I; Schultze-Seemann S; Taromi S; Gratzke C; Fuchs H; Wolf P
Front Pharmacol; 2023; 14():1211824. PubMed ID: 37484018
[TBL] [Abstract][Full Text] [Related]
54. Bioinformatic prediction and experimental validation of a PE38-based recombinant immunotoxin targeting the Fn14 receptor in cancer cells.
Keshtvarz M; Salimian J; Yaseri M; Bathaie SZ; Rezaie E; Aliramezani A; Norouzbabaei Z; Amani J; Douraghi M
Immunotherapy; 2017 Mar; 9(5):387-400. PubMed ID: 28357912
[TBL] [Abstract][Full Text] [Related]
55. Expression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to an EGF-receptor-specific antibody-toxin.
Schmidt M; Reiser P; Hills D; Gullick WJ; Wels W
Int J Cancer; 1998 Mar; 75(6):878-84. PubMed ID: 9506533
[TBL] [Abstract][Full Text] [Related]
56. Augmentation of the activity of an immunotoxin, anti-Tac(Fv)-PE40KDEL, in T cell lines infected with human T cell leukemia virus type-I.
Ohno N; Kreitman RJ; Saito T; Masamoto I; Uozumi K; Hanada S; Takeuchi S; Furukawa T; Sumizawa T; Arima T; Akiyama S
Leuk Lymphoma; 2002 Apr; 43(4):885-8. PubMed ID: 12153180
[TBL] [Abstract][Full Text] [Related]
57. The conjugation of an AQP1-directed immunotoxin in the study of site-directed therapy within the CNS.
Surash S; Nemeth P; Chakrabarty A; Chumas P
Childs Nerv Syst; 2011 May; 27(5):811-8. PubMed ID: 21104258
[TBL] [Abstract][Full Text] [Related]
58. An efficient scheme for purification of a novel recombinant immunotoxin, rCCK8PE38, for anti-tumour experiments.
Hu P; Zhang S; Lu SY; Li M; Chang J; Wang MY; Li C; Zhao K; Guan YT; Zhang YY; Li YS; Zhou Y; Liu ZS; Bai O; Ren HL
Biomed Chromatogr; 2018 Jun; 32(6):e4197. PubMed ID: 29359465
[TBL] [Abstract][Full Text] [Related]
59. Recombinant immunotoxin targeting GPC3 is cytotoxic to H446 small cell lung cancer cells.
Rodakowska E; Walczak-Drzewiecka A; Borowiec M; Gorzkiewicz M; Grzesik J; Ratajewski M; Rozanski M; Dastych J; Ginalski K; Rychlewski L
Oncol Lett; 2021 Mar; 21(3):222. PubMed ID: 33613711
[TBL] [Abstract][Full Text] [Related]
60. Production of a Granulysin-Based, Tn-Targeted Cytolytic Immunotoxin Using Pulsed Electric Field Technology.
Guerrero-Ochoa P; Aguilar-Machado D; Ibáñez-Pérez R; Macías-León J; Hurtado-Guerrero R; Raso J; Anel A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32859066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
